Clin Infect Dis 52(12):14581465 Reid E et al (2018) Cancer in people living with HIV, Version 1.2018, NCCN Clinical Practice Guidelines in Oncology
695069) and from The Independent Research Fund Denmark (DFF) (DFF 3101-00127B) to JJH and an unrestricted grant to JJH from the Novo Nordisk Center for Basic Metabolic Research (Novo Nordisk Foundation, Denmark)
It includes: One-on-one physician consultation Ongoing monthly clinical oversight and provider support Access to compounded GLP-1/GIP injections (if medically appropriate) Monthly medication supply from a licensed compounding pharmacy Optional wellness add-ons: lab testing, nutritional guidance, and more *Program starts at $400/month Who May Qualify This program may be appropriate for individuals who: Have a BMI of 30+, or 27+ with a related health condition Have not achieved success with other weight loss methods May not be candidates for brand-name GLP-1/GIP medications Want a clinically guided, structured approach to weight loss A thorough medical consultation will determine your eligibility and treatment plan
In the UK, Wegovy is prescribed through specialist weight management services according to NICE guidelines
In contrast, blood pressure benefits typically aren't maintained